Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 511 to 520

MELATONIN ARX melatonin 2 mg modified release tablet blister pack (250294)

4 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MELATONIN ARX melatonin 2 mg modified release tablet blister pack.
MELATONIN MR APOTEX melatonin 2 mg modified release tablet blister pack (250296)

4 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for MELATONIN MR APOTEX melatonin 2 mg modified release tablet blister pack.
CHEMMART MELATONIN MR melatonin 2 mg modified release tablet blister pack (250297)

4 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for CHEMMART MELATONIN MR melatonin 2 mg modified release tablet blister pack.
TERRY WHITE CHEMISTS MELATONIN MR melatonin 2 mg modified release tablet blister pack (250298)

4 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for TERRY WHITE CHEMISTS MELATONIN MR melatonin 2 mg modified release tablet blister pack.
BLOOMS THE CHEMIST MELATONIN MR melatonin 2 mg modified release tablet blister pack (250312)

4 April 2017

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BLOOMS THE CHEMIST MELATONIN MR melatonin 2 mg modified release tablet blister pack.
LAPELGA, NEUTROPEG (Apotex Pty Ltd)

24 July 2019

Prescription medicine registration

Active ingredients: pegfilgrastim.
CHEMMART PIOGLITAZONE pioglitazone 30 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
CHEMMART PIOGLITAZONE pioglitazone 15 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS PIOGLITAZONE pioglitazone 15 mg (as hydrochloride) tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd
TERRY WHITE CHEMISTS OLANZAPINE olanzapine 10 mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

28 June 2019

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 48
Page 49
Page 50
Page 51
Current page 52
Page 53
Page 54
Page 55
Page 56
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.